changes in protein profiles in bortezomib applied multiple myeloma ...
changes in protein profiles in bortezomib applied multiple myeloma ...
changes in protein profiles in bortezomib applied multiple myeloma ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
81<br />
18<br />
M5S<br />
Table 4.2. Results of Differential Prote<strong>in</strong>s Identified MALDI-TOF Mass Spectrometry (cont.)<br />
CLC5A<br />
C-type lect<strong>in</strong> doma<strong>in</strong><br />
family 5 member A<br />
19 M6S Unidentified<br />
20 M7S Unidentified<br />
21 M8S Unidentified<br />
22<br />
23<br />
S5C<br />
K5C<br />
CHIP<br />
E3 ubiquit<strong>in</strong>-prote<strong>in</strong><br />
ligase CHIP<br />
IKBD<br />
NF-kappa-B<br />
<strong>in</strong>hibitor delta<br />
24 K6C Unidentified<br />
25 S6C<br />
TNR17<br />
Tumor necrosis<br />
factor receptor<br />
superfamily member<br />
17<br />
26 K7C Unidentified<br />
MNWHMIISGLIVVVLKVVGMTLFLLYFPQIFNKSNDGFTTTRSYGTVSQIFGSSSPSPN<br />
GFITTRSYGTVCPKDWEFYQARCFFLSTSESSWNESRDFCKGKGSTLAIVNTPEKLKF<br />
LQDITDAEKYFIGLIYHREEKRWRWINNSVFNGNVTNQNQNFNCATIGLTKTFDAAS<br />
CDISYRRICEKNAK<br />
-<br />
-<br />
-<br />
MKGKEEKEGGARLGAGGGSPEKSPSAQELKEQGNRLFVGRKYPEAAACYGRAITRP<br />
LVAVYYTNRALCYLKQQHEQALADCRRALELDGQSVKAHFFLGQCQLEMESYDEAI<br />
ANLQRAYSLAKEQRLNFGDDIPSALRIAKKKRWNSIEERRIHQESELHSYLSRLIAAE<br />
RERELEECQRNHEGDEDDSHVRAQQACIEAKHDKYMADMDELFSQVDEKRKKRDI<br />
PDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFDPVTRSPLTQEQLIPNLAM<br />
KEVIDAFISENGWVEDY<br />
MEAGPWRVSAPPSGPPQFPAVVPGPSLEVARAHMLALGPQQLLAQDEEGDTLLHLF<br />
AARGLRWAAYAAAEVLQVYRRLDIREHKGKTPLLVAAAANQPLIVEDLLNLGAEPN<br />
AADHQGRSVLHVAATYGLPGVLLAVLNSGVQVDLEARDFEGLTPLHTAILALNVAM<br />
RPSDLCPRVLSTQARDRLDCVHMLLQMGANHTSQEIKSNKTVLHLAVQAANPTLVQ<br />
LLLELPRGDLRTFVNMKAHGNTALHMAAALPPGPAQEAIVRHLLAAGADPTLRNLE<br />
NEQPVHLLRPGPGPEGLRQLLKRSRVAPPG LSS<br />
-<br />
MLQMAGQCSQNEYFDSLLHACIPCQLRCSSNTPPLTCQRYCNASVTNSVKGTNAILW<br />
TCLGLSLIISLAVFVLMFLLRKINSEPLKDEFKNTGSGLLGMANIDLEKSRTGDEIILP<br />
RGLEYTVEECTCEDCIKSKPKVDSDHCFPLPAME<br />
EGATILVTTKTNDYCKSLPAALSATEIEKSISAR<br />
-<br />
6%<br />
21<br />
21.5/9.04<br />
- - -<br />
- - -<br />
- -<br />
7%<br />
3%<br />
22<br />
3<br />
34.8/5.61<br />
33.4/6.90<br />
- - -<br />
6%<br />
21<br />
20.1/5.24<br />
- - -<br />
cont. on next page<br />
81